Allakos Stock (NASDAQ: ALLK) stock price, news, charts, stock research, profile.
Open | $1.050 |
Close | $1.070 |
Volume / Avg. | 415.801K / 860.092K |
Day Range | 1.020 - 1.090 |
52 Wk Range | 1.000 - 5.640 |
Market Cap | $91.389M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 8.29% |
Days to Cover | 10.02 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Allakos (NASDAQ: ALLK) through any online brokerage.
Other companies in Allakos’s space includes: Anixa Biosciences (NASDAQ:ANIX), Cellectar Biosciences (NASDAQ:CLRB), Curis (NASDAQ:CRIS), Connect Biopharma Hldgs (NASDAQ:CNTB) and Burning Rock Biotech (NASDAQ:BNR).
The latest price target for Allakos (NASDAQ: ALLK) was reported by JMP Securities on Wednesday, January 17, 2024. The analyst firm set a price target for 3.00 expecting ALLK to rise to within 12 months (a possible 188.46% upside). 10 analyst firms have reported ratings in the last year.
The stock price for Allakos (NASDAQ: ALLK) is $1.04 last updated April 19, 2024 at 9:23 AM EDT.
There are no upcoming dividends for Allakos.
Allakos’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Allakos.
Allakos is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.